Active constituents
Black cohosh contains a few ingredients, including triterpene glycosides (for example, acetin and 27-deoxyactein) and isoflavones (for example, formononetin). Other constituents include aromatic acids, tannins, resins, fatty acids, starches, and sugars. As a woman approaches menopause, the signals between the ovaries and pituitary gland diminish, slowing down oestrogen production and increasing luteinising hormone (LH) secretions. Hot flushes can result from these hormonal changes. Earlier animal studies4 5 and a human clinical trial6 suggested that black cohosh had some oestrogen activity in the body and also decreased LH secretions. However, more recent animal studies7 and a clinical trial8 have found no oestrogen activity for black cohosh extracts. Further clinical trials are needed to determine whether black cohosh has significant oestrogenic actions in the body.
Small German clinical trials support the usefulness of black cohosh for women with hot flushes associated with menopause.9 10 A review of eight clinical trials found black cohosh to be both safe and effective for symptomatic relief of menopausal hot flushes.11 Other symptoms which improved included night sweats, insomnia, nervousness, and irritability. A clinical trial compared the effects of 40 mg versus 130 mg of black cohosh in menopausal women with complaints of hot flushes.12 While hot flushes were reduced equally at both amounts, there was no evidence of any oestrogenic effect in any of the women. Although further trials are needed, this trial suggests that black cohosh is best reserved only for the symptomatic treatment of hot flushes associated with menopause and is not thought to be a substitute for hormone replacement therapy in menopausal and postmenopausal women.
A recent study suggests black cohosh may protect animals from osteoporosis.13 Human studies have not confirmed this action.
References
1. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996, 88–9.
2. Castleman M. The Healing Herbs. Emmaus, PA: Rodale Press, 1991, 75–8.
3. Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 12–3.
4. Jarry H, Harnischfeger G, Düker E. Studies on endocrine effects of the contents of Cimicifuga racemosa. 2. In vitro binding of compounds to estrogen receptors. Planta Medica 1985;51:316–9.
5. Jarry H, Harnischfeger G. Studies on endocrine effects of the contents of Cimicifuga racemosa. 1. Influence on the serum concentration of pituitary hormones in ovariectomized rats. Planta Medica 1985;51:46–9.
6. Düker EM, Kopanski L, Jarry H, Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Medica 1991;57:420–4.
7. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K. Cimicifuga and Melbrosia lack estrogenic effects in mice and rats. Maturitas 1996;25:149–53.
8. Liske E, Wüstenberg P, Boblitz N. Human pharmacological investigations during treatment of climacteric complaints with Cimicifuga racemosa (Remifemin®): No estrogen-like effects [Poster presentation]. 2nd International Congress on Phytomedicine, London, October 15–16, 1998.
9. Stoll W. Phytopharmaceutical influences atrophic vaginal epithelium. Double-blind study on Cimicifuga versus an estrogen preparation. Therapeutikon 1987;1:23–32.
10. Warnecke G. Using phyto-treatment to influence menopause symptoms. Med Welt 1985;36:871–4.
11. Düker EM, Kopanski L, Jarry H, Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Medica 1991;57:420–4.
12. Liske E, Wüstenberg P. Therapy of climacteric complaints with Cimicifuga racemosa: a herbal medicine with clinically proven evidence [Abstract #98.0020]. Poster Presentation, 9th Annual Meeting of the North American Menopause Society, Toronto, Canada, September 16–9, 1998.
13. Kadota S, Li JX, Litt Y, et al. Effects of cimicifugae rhizome on serum calcium and phosphate levels in low calcium dietary rats and on bone mineral density in ovariectomized rats. Phytomed 1996/7;3:379–85.
14. Murray MT. The Healing Power of Herbs. Rocklin, CA: Prima Publishing, 1995, 376.
15. Bradley PR, ed. British Herbal Compendium, vol 1. Bournemouth, Dorset, UK: British Herbal Medicine Association, 1992, 34–6.
16. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 90.
17. Gruenwald J. Standardized black cohosh (Cimicifuga) extract clinical monograph. Quart Rev Nat Med 1998;Summer:117–25.
18. Cohen SM, O'Connor AM, Hart J, et al. Autoimmune hepatitis
associated with the use of black cohosh: a case study. Menopause 2004;11:575–7.
19. Levitsky J, Alli TA, Wisecarver J, Sorrell MF. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 2005;50:538–9.